본문

ScienceON 검색

ScienceON '특허' 검색

MORE
국가과학기술정보센터(ScienceON) 특허검색
No 제목 / 내용
1 METHOD FOR ENZYMATICALLY PRODUCING MAYTANSINOL / MICROBIOPHARM JAPAN CO., LTD.
The present invention addresses the problem of providing a technique related to a method for enzymatically producing maytansinol from ansamitocins such as AP3. Provided is a method for producing maytansinol, the method including a step for enzymatically generating maytansinol from ansamitocins using one protein of (A)-(F) and (AA)-(CC): (A) a protein comprising the amino acid sequence represented by SEQ ID NO:9; (B) a protein comprising the amino acid sequence represented by SEQ ID NO: 9 with one or more amino acids substituted, deleted, inserted and/or added, where positions 66-68 correspond to residues DLL or AGA, positions 139-141 correspond to residues GPF, positions 146-148 correspond to residues LSS or LSP, positions 247-249 correspond to residues LHT, position 323 corresponds to residues HSX or ASX (where X is Q, K, E or M), positions 374-376 correspond to residues QSX (where X is H, R, D or Q), positions 443-445 correspond to residues GNP, and having activity for catalyzing a reaction that produces maytansinol from ansamitocins; (C) a protein having at least 50% amino acid identity with the amino acid sequence represented by SEQ ID NO: 9, where positions 66-68 correspond to residues DLL or AGA, positions 139-141 correspond to residues GPF, positions 146-148 correspond to residues LSS or LSP, positions 247-249 correspond to residues LHT, positions 323 correspond to residues HSX or ASX (where X is Q, K, E or M), positions 374-376 correspond to residues QSX (where X is H, R, D or Q), positions 443-445 correspond to residues GNP, and having activity for catalyzing a reaction that produces maytansinol from ansamitocins; (D) a protein comprising the amino acid sequence represented by SEQ ID NO: 12; (E) a protein comprising the amino acid sequence represented by SEQ ID NO: 12 with one or more amino acids substituted, deleted, inserted and/or added, where positions 66-68 correspond to residues DLL or AGA, positions 139-141 correspond to residues GPF, positions 146-148 correspond to residues LSS or LSP, positions 247-249 correspond to residues LHT, position 323 corresponds to residues HSX or ASX (where X is Q, K, E or M), positions 374-376 correspond to residues QSX (where X is H, R, D or Q), positions 443-445 correspond to residues GNP, and having activity for catalyzing a reaction that produces maytansinol from ansamitocins; (F) a protein having at least 50% amino acid identity with the amino acid sequence represented by SEQ ID NO: 12, where positions 66-68 correspond to residues DLL or AGA, positions 139-141 correspond to residues GPF, positions 146-148 correspond to residues LSS or LSP, positions 247-249 correspond to residues LHT, position 323 corresponds to residues HSX or ASX (where X is Q, K, E or M), positions 374-376 correspond to residues QSX (where X is H, R, D or Q), positions 443-445 correspond to residues GNP, and having activity for catalyzing a reaction that produces maytansinol from ansamitocins; (AA) a protein comprising the amino acid sequence represented by any one of SEQ ID NOs:18-21; (BB) a protein comprising the amino acid sequence represented by any one of SEQ ID NOs:18-21 with one or more amino acids substituted, deleted, inserted and/or added, and having activity for catalyzing a reaction that produces maytansinol from ansamitocins; and (CC) a protein having at least 80% amino acid identity with the amino acid sequence represented by any one of SEQ ID NOs:18-21, and having activity for catalyzing a reaction that produces maytansinol from ansamitocins.
2 TRUNK LINE DISPLAY DEVICE / TOSHIBA CORP
(PURPOSE) To know an extension number in specific relation with a trunk line at a glance and to carry out office work properly and also improve the service to a station calling opponent by varying and displaying the extension number at a position corresponding to a trunk line number on the display device. (CONSTITUTION) Display panels 111 , 112 ...118 on which trunk line numbers of trunk lines assigned to tenants are displayed are provided on the surface of the display device 6, and LEDs 131 , 132 ...138 as display elements capable of varying and displaying one extension number are provided at the right-hand side of the display panel. Then, a central controller CC4 is connected to an I/O port 23, latches 241 , 242 ...249 including a holding circuit for extension number data are connected to the port 23, and decoder drivers 251 , 252 ...259 are connected to those latches. Those latches 241 ...248 and drivers 251 ...258 constitute a display controller 26 which displays extension numbers on the LEDs 131 ...138 on the basis of extension number data.
3 METHOD FOR ENZYMATICALLY PRODUCING MAYTANSINOL / MicroBiopharm Japan Co., Ltd.
An object of the present invention is to provide a technique relating to a method for enzymatically producing maytansinol from an ansamitocin species such as AP3. A method for producing maytansinol, which comprises enzymatically producing maytansinol from an ansamitocin species with any one of the proteins (A) to (F) and (AA) to (CC) mentioned below: (A) a protein consisting of the amino acid sequence of SEQ ID NO: 9; (B) a protein consisting of an amino acid sequence derived from the amino acid sequence of SEQ ID NO: 9 by substitution, deletion, insertion, and/or addition of one or more amino acids, wherein amino acids corresponding to the positions 66 to 68 are DLL or AGA, amino acids corresponding to the positions 139 to 141 are GPF, amino acids corresponding to the positions 146 to 148 are LSS or LSP, amino acids corresponding to the positions 247 to 249 are LHT, amino acids corresponding to the position 323 are HSX or ASX (where X is Q, K, E, or M), amino acids corresponding to the positions 374 to 376 are QSX (where X is H, R, D, or Q), and amino acids corresponding to the positions 443 to 445 are GNP, and having an activity for catalyzing a reaction of producing maytansinol from an ansamitocin species; (C) a protein consisting of an amino acid sequence having an identity of at least 50% to the amino acid sequence of SEQ ID NO: 9, wherein amino acids corresponding to the positions 66 to 68 are DLL or AGA, amino acids corresponding to the positions 139 to 141 are GPF, amino acids corresponding to the positions 146 to 148 are LSS or LSP, amino acids corresponding to the positions 247 to 249 are LHT, amino acids corresponding to the position 323 are HSX or ASX (where X is Q, K, E, or M), amino acids corresponding to the positions 374 to 376 are QSX (where X is H, R, D, or Q), and amino acids corresponding to the positions 443 to 445 are GNP, and having an activity for catalyzing a reaction of producing maytansinol from an ansamitocin species; (D) a protein consisting of the amino acid sequence of SEQ ID NO: 12; (E) a protein consisting of an amino acid sequence derived from the amino acid sequence of SEQ ID NO: 12 by substitution, deletion, insertion, and/or addition of one or more amino acids, wherein amino acids corresponding to the positions 66 to 68 are DLL or AGA, amino acids corresponding to the positions 139 to 141 are GPF, amino acids corresponding to the positions 146 to 148 are LSS or LSP, amino acids corresponding to the positions 247 to 249 are LHT, amino acids corresponding to the position 323 are HSX or ASX (where X is Q, K, E, or M), amino acids corresponding to the positions 374 to 376 are QSX (where X is H, R, D, or Q), and amino acids corresponding to the positions 443 to 445 are GNP, and having an activity for catalyzing a reaction of producing maytansinol from an ansamitocin species; (F) a protein consisting of an amino acid sequence having an identity of at least 50% to the amino acid sequence of SEQ ID NO: 12, wherein amino acids corresponding to the positions 66 to 68 are DLL or AGA, amino acids corresponding to the positions 139 to 141 are GPF, amino acids corresponding to the positions 146 to 148 are LSS or LSP, amino acids corresponding to the positions 247 to 249 are LHT, amino acids corresponding to the position 323 are HSX or ASX (where X is Q, K, E, or M), amino acids corresponding to the positions 374 to 376 are QSX (where X is H, R, D, or Q), and amino acids corresponding to the positions 443 to 445 are GNP, and having an activity for catalyzing a reaction of producing maytansinol from an ansamitocin species; (AA) a protein consisting of any one of the amino acid sequences of SEQ ID NOS: 18 to 21; (BB) a protein consisting of an amino acid sequence derived from any one of the amino acid sequences of SEQ ID NOS: 18 to 21 by substitution, deletion, insertion, and/or addition of one or more amino acids, and having an activity for catalyzing a reaction of producing maytansinol from an ansamitocin species; and (CC) a protein consisting of an amino acid sequence having an identity of at least 80% to any one of the amino acid sequences of SEQ ID NOS: 18 to 21, and having an activity for catalyzing a reaction of producing maytansinol from an ansamitocin species.

ScienceON '논문' 검색

MORE
ScienceON 논문 검색
No 제목 / 내용
1 A Possible Dynamically Cold Classical Contact Binary: (126719) 2002 CC<sub>249</sub>
American Astronomical Society , 2017 ; Vol. 154 , Issue 6
2 'A Comedy of Errors': Parliament's Conduct in Relation to the Tabling of a Motion of No Confidence in the President Mazibuko v Sisulu 2013 6 SA 249; 2013 11 BCLR 1297 (CC)
UNISA Press , 2015 ; Vol. 30 , Issue 1
3 Calcareous nannofossil biostratigraphy and paleoceanography of late cretaceous Indian ocean
University of Nebraska , 1994 ; 국외박사 , 120 p.
4 Calcareous nannofossil biostratigraphy and paleoceanography of late cretaceous Indian ocean
University of Nebraska , 1999 ; 국외박사 , pp.56-67
5 Calcareous nannofossil biostratigraphy and paleoceanography of late cretaceous Indian ocean
University of Nebraska , 2012 ; 국외박사 , pp.92-97
6 Calcareous nannofossil biostratigraphy and paleoceanography of late cretaceous Indian ocean
University of Nebraska , 2022 ; 국외박사 , pp.155-160
7 Calcareous nannofossil biostratigraphy and paleoceanography of late cretaceous Indian ocean
University of Nebraska , 1977 ; 국외박사 , pp.245-247
8 양극성 장애에서 일주기 위상 변이와 임상 양상의 일주기 유전자와의 연합 연구
울산대학교 , 2007 ; 국내박사 , v, 29장
9 양극성 장애에서 일주기 위상 변이와 임상 양상의 일주기 유전자와의 연합 연구
울산대학교 , 2006 ; 국내박사 , pp.73-80
10 양극성 장애에서 일주기 위상 변이와 임상 양상의 일주기 유전자와의 연합 연구
울산대학교 , 2002 ; 국내박사 , pp.249-258

ScienceON '보고서' 검색

MORE